Oral Magnesium Protocol for Atrial Fibrillation Rhythm Conversion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for converting atrial fibrillation (AF) to sinus rhythm (SR) are costly, risky, and often ineffective due to short-term Mg supplementation, which does not address intracellular Mg deficiencies and require frequent interventions, posing risks such as stroke and recurrence.

Innovation Solution

A low-cost, long-term oral Mg and K supplementation protocol combined with frequent EKG monitoring, hydration management, and consumption of Mg and K-rich foods to normalize intracellular Mg levels and maintain stable electrolyte balance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If short-term Mg supplementation is used to convert AF to SR, then conversion may be achieved, but intracellular Mg deficiencies are not addressed and recurrence risk increases

Engineering Contradiction:
Improveconversion effectivenessVSAvoidsupplementation duration
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The protocol performs preliminary assessment of intracellular Mg levels through clinical evaluation of AF history and risk factors before initiating supplementation. This preliminary action identifies patients with intracellular Mg deficiency who will benefit from long-term supplementation, ensuring the treatment addresses the root cause rather than just symptomatic conversion.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The protocol implements continuous long-term Mg supplementation (typically 3-6 months or longer) rather than short-term intermittent dosing. This continuous action maintains stable serum Mg levels and ensures adequate intracellular repletion, preventing recurrence by addressing the underlying deficiency that short-term protocols fail to correct.

Inventive Principle:
Principle #20Continuity of useful action

2Reliability

If frequent interventions are performed to convert AF to SR, then conversion success may improve, but stroke risk and procedural risks increase

Engineering Contradiction:
Improveconversion success rateVSAvoidstroke risk
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The protocol empowers patients to self-monitor their heart rhythm using portable EKG devices and track their own AF episodes. Patients can identify patterns and trigger factors, and the protocol includes self-management strategies for maintaining SR, reducing the need for frequent medical interventions while keeping patients actively engaged in their own care.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The protocol incorporates regular follow-up EKG monitoring (initially frequent, then spaced out) to provide feedback on conversion success and SR maintenance. This feedback loop allows clinicians to adjust supplementation dosing and provide guidance based on objective data, reducing unnecessary interventions while ensuring timely response to recurrence.

Inventive Principle:
Principle #23Feedback

3Reliability

If conventional treatment protocols are used, then AF conversion may be achieved, but costs are high and accessibility is limited

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidtreatment accessibility
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The protocol uses inexpensive oral Mg supplements (available as over-the-counter medications or dietary supplements) rather than expensive hospital-based procedures like catheter ablation or repeated electrical cardioversion. The supplements can be taken at home without specialized equipment or facilities, dramatically improving accessibility while maintaining effectiveness for patients with intracellular Mg deficiency.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

Solution Approach 2:

The protocol addresses multiple aspects of AF management with a single comprehensive approach: it corrects intracellular Mg deficiency, maintains serum electrolyte balance, prevents recurrence, and provides a framework for patient self-monitoring. This multi-functional protocol replaces multiple separate expensive interventions with one unified, accessible treatment strategy.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS12558373B1Method for converting atrial fibrillation to sinus rhythm with low-risk, low-cost protocol, and preventing recurrence of atrial fibrillation
Publication Date: 2026.02.24 WANDERER ALAN
  • US12558373B1 patent drawing

AI summary

The method is for treating an individual having atrial fibrillation (AF) with administration of oral magnesium supplementation for converting atrial fibrillation to sinus rhythm. The method includes monitoring cardiac rhythms frequently (e.g. daily), importance of remaining hydrated, adding potassium if needed, and administering a dose of oral magnesium supplements for at least four to six weeks, for example. The method includes titrating the dose of magnesium supplements until conversion of atrial fibrillation to sinus rhythm, and additional titrating of the dose of magnesium supplements based upon recurrence of atrial fibrillation, until conversion of atrial fibrillation to sinus rhythm. Monitoring ‘Heart Rate Variability” in certain circumstances may forecast the presence or recurrence of atrial fibrillation.